A New Era in Down Syndrome Screening: Integrated Risk Assessment

  • Duration:

Price: $59.00

Member Price: $49.00

Rating: Member Average

This is a recorded version of the AACC webinar "A New Era in Down Syndrome Screening: Integrated Risk Assessment," which was originally held December 7, 2011. For more than four decades, prenatal screening for Down syndrome has been an important component in care of the maternal/fetal unit. During this program, top maternal/fetal experts discuss how lab tests are being used in this important area of medicine, examining the advantages and caveats of first-trimester screening as well as the importance of ultrasound dating and its impact on interpretation of biochemical test results. Also covered are new biochemical and ultrasound markers; the role of each component in the second trimester quad screen; issues surrounding integrated screening; and emerging biochemical tools for assessing pregnancy.